Verrucous hemangioma: A clinicopathological and immunohistochemical analysis of 74 cases

Journal of Cutaneous Pathology

Volumn 41, Issue 11, 2014, Pages 823-830

  Wang, Lei ^a   Gao, Tianwen ^a   Wang, Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

D2 40; Prox1; verrucous hemangioma; Wilms tumor 1

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; CHILD; FEMALE; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LYMPH VESSEL; MALE; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; SKIN TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHATIC VESSELS; MALE; MIDDLE AGED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84913586717     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12385     Document Type: Article

References (31)

1. Imperial R, Helwig EB,. Verrucous hemangioma. A clinicopathologic study of 21 cases. Arch Dermatol 1967; 96: 247.
2. Yang CH, Ohara K,. Successful surgical treatment of verrucous hemangioma: a combined approach. Dermatol Surg 2002; 28: 913.
3. Tennant LB, Mulliken JB, Perez-Atayde AR, Kozakewich HP,. Verrucous hemangioma revisited. Pediatr Dermatol 2006; 23: 208.
4. Trindade F, Torrelo A, Requena L, et al. An immunohistochemical study of verrucous hemangiomas. J Cutan Pathol 2013; 40: 472.
5. Wentscher U, Happle R,. Linear verrucous hemangioma. J Am Acad Dermatol 2000; 42: 516.
6. Hayashi H, Shimizu T, Nakamura H, Shimizu H,. Linear verrucous haemangioma on the abdomen. Acta Derm Venereol 2004; 84: 79.
7. Wang G, Li C, Gao T,. Verrucous hemangioma. Int J Dermatol 2004; 43: 745.
8. Clairwood MQ, Bruckner AL, Dadras SS,. Verrucous hemangioma: a report of two cases and review of the literature. J Cutan Pathol 2011; 38: 740.
9. Laing EL, Brasch HD, Steel R, et al. Verrucous hemangioma expresses primitive markers. J Cutan Pathol 2013; 40: 391.
10. Tsuji T, Sawada H,. Eccrine angiomatous hamartoma with verrucous features. Br J Dermatol 1999; 141: 167.
11. Galan A, McNiff JM,. Eccrine angiomatous hamartoma with features resembling verrucous hemangioma. J Cutan Pathol 2007; 34 (S1): 68.
12. Cheong SH, Lim JY, Kim SY, Choi YW, Choi HY, Myung KB,. A case of eccrine angiomatous hamartoma associated with verrucous hemangioma. Ann Dermatol 2009; 21: 304.
13. Holcomb M, Sun G, Eldin K, Brandon K,. Verrucous hyperpigmented plaque in a 15-month-old boy. Eccrine angiomatous hamartoma (EAH) associated with verrucous hemangioma (verrucous hemangioma). Int J Dermatol 2013; 52: 25.
14. Fathaddin AA, Alhumidi AA,. Eccrine angiomatous hamartoma, with verrocous hemangioma-like features: a case report. Int J Health Sci (Qassim) 2013; 7: 103.
15. Kazakov DV, Michal M, Kacerovska D, McKee P,. Cutaneous adnexal tumors. Philadelphia: Lippincott Williams & Wilkins Health, 2012; 158.
16. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002; 7: 1505.
17. Hirakawa S, Hong YK, Harvey N, et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 2003; 162: 575.
18. Hong YK, Detmar M,. Prox1, master regulator of the lymphatic vasculature phenotype. Cell Tissue Res 2003; 314: 85.
19. Wilting J, Papoutsi M, Christ B, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002; 16: 1271.
20. Castro EC, Galambos C,. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations-a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations. Pediatr Dev Pathol 2009; 12: 187.
21. Miettinen M, Wang ZF,. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Am J Surg Pathol 2012; 36: 351.
22. Le Huu AR, Jokinen CH, Rubin BP, et al. Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol 2010; 34: 1563.
23. Wang L, Gao T, Wang G,. Expression of Prox1, D2-40, and WT1 in spindle cell hemangioma. J Cutan Pathol 2014; 41: 447.
24. Wang L, Yuan W, Geng S, et al. Expression of lymphatic markers in angiokeratomas. J Cutan Pathol 2014. DOI: 10.1111/cup.12349.
25. Akishima Y, Ito K, Zhang L, et al. Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch 2004; 444: 153.
26. Bhawan J, Silva C, Taungjaruwinai WM,. Inconsistent immunohistochemical expression of lymphatic and blood endothelial cell markers in cutaneous lymphangiomas. J Cutan Pathol 2013; 40: 801.
27. Trindade F, Tellechea O, Torrelo A, Requena L, Colmenero I,. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol 2011; 33: 569.
28. Al Dhaybi R, Powell J, McCuaig C, Kokta V,. Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 2010; 63: 1052.
29. Fernandez-Flores A, Saeb-Lima M,. Correct evaluation and interpretation of WT-1 immunostaining in vascular lesions. J Cutan Pathol 2014; 41: 754.
30. North PE, Waner M, Mizeracki A, Mihm MC Jr,. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11.
31. Leon-Villapalos J, Wolfe K, Kangesu L,. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005; 58: 348.